{"id":55767,"date":"2022-05-20T11:19:00","date_gmt":"2022-05-20T11:19:00","guid":{"rendered":"https:\/\/www.mymsd.ch\/fr\/?p=55767"},"modified":"2025-11-23T18:15:22","modified_gmt":"2025-11-23T18:15:22","slug":"keytruda-en-cas-de-metastases-cerebrales-avancees-nsclc","status":"publish","type":"post","link":"https:\/\/www.mymsd.ch\/fr\/oncology\/onco-news\/keytruda-en-cas-de-metastases-cerebrales-avancees-nsclc\/","title":{"rendered":"KEYTRUDA\u00ae en monoth\u00e9rapie et en association en cas de m\u00e9tastases c\u00e9r\u00e9brales d\u2019un NSCLC avanc\u00e9"},"content":{"rendered":"\n<figure class=\"wp-block-image size-full\"><img loading=\"lazy\" decoding=\"async\" width=\"1200\" height=\"367\" src=\"https:\/\/www.mymsd.ch\/fr\/wp-content\/uploads\/sites\/30\/2022\/11\/KEYTRUDA-en-monotherapie_L.png\" alt=\"Clinician holding a stylized antibody next to Keytruda branding and text about treatment possibilities\" class=\"wp-image-67168\" srcset=\"https:\/\/www.mymsd.ch\/fr\/wp-content\/uploads\/sites\/30\/2022\/11\/KEYTRUDA-en-monotherapie_L.png 1200w, https:\/\/www.mymsd.ch\/fr\/wp-content\/uploads\/sites\/30\/2022\/11\/KEYTRUDA-en-monotherapie_L.png?resize=300,92 300w, https:\/\/www.mymsd.ch\/fr\/wp-content\/uploads\/sites\/30\/2022\/11\/KEYTRUDA-en-monotherapie_L.png?resize=768,235 768w, https:\/\/www.mymsd.ch\/fr\/wp-content\/uploads\/sites\/30\/2022\/11\/KEYTRUDA-en-monotherapie_L.png?resize=1024,313 1024w, https:\/\/www.mymsd.ch\/fr\/wp-content\/uploads\/sites\/30\/2022\/11\/KEYTRUDA-en-monotherapie_L.png?resize=320,98 320w, https:\/\/www.mymsd.ch\/fr\/wp-content\/uploads\/sites\/30\/2022\/11\/KEYTRUDA-en-monotherapie_L.png?resize=120,37 120w\" sizes=\"auto, (max-width: 1200px) 100vw, 1200px\" \/><\/figure>\n\n\n\n<h3 class=\"wp-block-heading has-positive-3-font-size has-border-color has-has-red-border-color-border-color  mhh-mcn-v1-heading mhh-mcn-v1-heading--692eca2cb13ddbb0cb571cee6e43e6b2\"><mark style=\"background-color:#ffffff\" class=\"has-inline-color has-teal-color\">Les analyses group\u00e9es des \u00e9tudes KEYNOTE sur le mNSCLC ont montr\u00e9 un avantage en termes de survie globale m\u00eame chez les patientes et patients atteints de mNSCLC qui pr\u00e9sentaient des m\u00e9tastases c\u00e9r\u00e9brales.<\/mark><\/h3>\n\n\n\n<p class=\"has-positive-1-font-size has-border-color has-has-red-border-color-border-color   mhh-mcn-v1-paragraph mhh-mcn-v1-paragraph--4e65f06dc303182e048ae44d65a4f4f2\"><strong>\u00c0 retenir<\/strong><\/p>\n\n\n\n<ul class=\"mhh-mcn-v2-clist mhh-mcn-v2-clist--2495ef7de1791ac855e2c1b46279e5b6 mhh-mcn-list mhh-mcn-v2-clist--unordered mhh-mcn-v2-clist--unordered-line\" dir=\"ltr\" lang=\"fr-FR\" start=\"1\">\n    \n<li class=\"mhh-mcn-list-item mhh-mcn-v2-list-item\">\n    L\u2019association KEYTRUDA\u00ae + chimioth\u00e9rapie peut am\u00e9liorer les r\u00e9sultats cliniques par rapport \u00e0 la chimioth\u00e9rapie seule, les patients ayant ou non des m\u00e9tastases c\u00e9r\u00e9brales.<sup>2<\/sup>    <\/li>\n\n\n<li class=\"mhh-mcn-list-item mhh-mcn-v2-list-item\">\n    KEYTRUDA\u00ae en monoth\u00e9rapie peut am\u00e9liorer les r\u00e9sultats cliniques par rapport \u00e0 une chimioth\u00e9rapie seule, que le patient ait ou non une m\u00e9tastase c\u00e9r\u00e9brale stable pr\u00e9alablement trait\u00e9e.<sup>3<\/sup>    <\/li>\n\n\n<li class=\"mhh-mcn-list-item mhh-mcn-v2-list-item\">\n    KEYTRUDA\u00ae en monoth\u00e9rapie et en association, pr\u00e9sente un profil de s\u00e9curit\u00e9 connu et g\u00e9rable.<sup>2,3<\/sup>    <\/li>\n\n<\/ul>\n\n\n\n<p class=\"has-positive-1-font-size has-border-color has-has-red-border-color-border-color   mhh-mcn-v1-paragraph mhh-mcn-v1-paragraph--3ef642dac0139b12d760d975fdbded18\"><strong>Cliquez sur les liens ci-dessous pour d\u00e9couvrir les donn\u00e9es r\u00e9sum\u00e9es ou les publications originales.<\/strong><\/p>\n\n\n<div class=\"mhh-mcn-v1-links mhh-mcn-v1-links--a8411eb2c67f8af327eed15c73cf4dcc\">\n    <a class=\"mhh-mcn-v1-link mhh-mcn-v1-link--35bffaa1f334063a9ce3b735fd648a55 mhh-mcn-v1-link--is-variation mhh-mcn-v1-link--button-primary\" href=\"https:\/\/www.mymsd.ch\/de\/wp-content\/uploads\/sites\/13\/2022\/05\/MSD2589-KEY-Lung-BrainMets-LB-FR-V08-LR-ES.pdf\" target=\"_self\" aria-label=\"Lien vers le r\u00e9sum\u00e9\">\n                    <span class=\"mhh-mcn-v1-link__label\">Lien vers le r\u00e9sum\u00e9<\/span>\n                <\/a><\/div>\n\n\n\n<hr class=\"wp-block-separator has-css-opacity\" \/>\n\n\n<div class=\"mhh-mcn-v1-links mhh-mcn-v1-links--5e5ac8ac475ccc77fedf43a99bd7280f\">\n    <a class=\"mhh-mcn-v1-link mhh-mcn-v1-link--b68f7c955f2a083afed2566bcd2189ab mhh-mcn-v1-link--is-variation mhh-mcn-v1-link--button-custom\" href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/34265431\/\" target=\"_blank\" rel=\"noopener noreferrer\" aria-label=\"Lien vers la premi\u00e8re \u00e9tude (Powell SF et al.)\">\n                    <span class=\"mhh-mcn-v1-link__label\">Lien vers la premi\u00e8re \u00e9tude (Powell SF et al.)<\/span>\n                <\/a>\n\n\n\n    <a class=\"mhh-mcn-v1-link mhh-mcn-v1-link--e5c4dd211739f1b1669339083cbee06b mhh-mcn-v1-link--is-variation mhh-mcn-v1-link--button-primary\" href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/34590048\/\" target=\"_blank\" rel=\"noopener noreferrer\" aria-label=\"Lien vers la deuxi\u00e8me \u00e9tude (Mansfield AS et al.)\">\n                    <span class=\"mhh-mcn-v1-link__label\">Lien vers la deuxi\u00e8me \u00e9tude (Mansfield AS et al.)<\/span>\n                <\/a><\/div>\n\n\n\n<div style=\"height:50px\" aria-hidden=\"true\" class=\"wp-block-spacer\"><\/div>\n\n\n\r\n<div class=\"inpsyde-iframe is-responsive has-transparent-background-color\">\r\n    <iframe loading=\"lazy\" height=\"400\" referrerpolicy=\"no-referrer-when-downgrade\" title=\"Ce contenu vous a-t-il \u00e9t\u00e9 pertinent ?\" src=\"https:\/\/go.screver.com\/msd-ch-cx\/newsroom-articles?lang=fr&amp;hideHeader=true\" width=\"100%\"><\/iframe>\r\n<\/div>\n\n\n<nav class=\"wp-block-mconnect-theme-related-content has-background has-light-grey-background-color\">\n\t<div class=\"wp-block-mconnect-theme-related-content__container\">\n\t\t\t\t\t<h3 class=\"wp-block-mconnect-theme-related-content__title\">\n\t\t\t\tContenu connexe\t\t\t<\/h3>\n\t\t\n\t\t\t\t\t<ul class=\"is-grid-layout has-columns has-three-columns has-top-vertical-alignment\">\n\t\t\t\t\n\n\n\n\n\n\t\t\t\t\t\t<li class=\"grid-item\">\n\t\t\t\t\t\t\t<article\n    class=\"content-item content-item-type-post is-display-media-style has-featured-image has-background has-white-background-color has-link post-94771 post type-post status-publish format-standard has-post-thumbnail hentry category-onco-news category-oncology tag-keytruda tag-keytruda-2 tag-nsclc\">\n\t\t\t<div class=\"content-item__media-container\">\n\t\t\t<div class=\"content-media\">\n\t\t\t\t<div class=\"content-media__inner\">\n\t\t\t\t\t<img loading=\"lazy\" decoding=\"async\" width=\"635\" height=\"475\" src=\"https:\/\/www.mymsd.ch\/fr\/wp-content\/uploads\/sites\/30\/2024\/04\/Keytruda_banner_box_fr.jpg?w=635&amp;h=475&amp;crop=1\" class=\"content-media__image\" alt=\"\" srcset=\"https:\/\/www.mymsd.ch\/fr\/wp-content\/uploads\/sites\/30\/2024\/04\/Keytruda_banner_box_fr.jpg 635w, https:\/\/www.mymsd.ch\/fr\/wp-content\/uploads\/sites\/30\/2024\/04\/Keytruda_banner_box_fr.jpg?resize=300,224 300w, https:\/\/www.mymsd.ch\/fr\/wp-content\/uploads\/sites\/30\/2024\/04\/Keytruda_banner_box_fr.jpg?resize=320,239 320w, https:\/\/www.mymsd.ch\/fr\/wp-content\/uploads\/sites\/30\/2024\/04\/Keytruda_banner_box_fr.jpg?resize=120,90 120w, https:\/\/www.mymsd.ch\/fr\/wp-content\/uploads\/sites\/30\/2024\/04\/Keytruda_banner_box_fr.jpg?resize=180,135 180w\" sizes=\"auto, (max-width: 635px) 100vw, 635px\" \/>\t\t\t\t<\/div>\n\t\t\t<\/div>\n\t\t<\/div>\n\t\n    \n    <div class=\"content-item__content-container\">\n\t\t<div class=\"content-item__content-body\">\n\t\t\t\t\t\t\t\t\t\t<span\n\t\t\t\t\tclass=\"content-item__primary-tag\"\n\t\t\t\t\ttitle=\"Cet article a \u00e9t\u00e9 \u00e9tiquet\u00e9 comme : NSCLC\"\n\t\t\t\t>\n\t\t\t\t\tNSCLC\t\t\t\t<\/span>\n\t\t\t\t\t\t<header class=\"content-item__header\">\n\t\t\t\t<span\n\t\t\t\t\tclass=\"content-item__content-type content-type  content-type--post\">\n\t\t\t\t\t<span class=\"content-type__icon\">\n                                            <\/span>\n\t\t\t\t\t\t\t\t\t<\/span>\n\t\t\t\t<h2 class=\"content-item__title\" data-enterprise-id=\"currentHeader\">\n\t\t\t\t\t\t\t\t\t\t\t<a href=\"https:\/\/www.mymsd.ch\/fr\/oncology\/onco-news\/pd-l1-resultats-a-5-ans-issus-de-kn-189-et-kn-407\/\"\n                            class=\"content-item__title-link\"\n                            target=\"_self\"\n                            rel=\"\"\n\t\t\t\t\t\t\t              >\n                            PD-L1 (-): r\u00e9sultats \u00e0 5\u00a0ans issus de KN-189 et KN-407                        <\/a>\n\t\t\t\t\t\t\t\t\t<\/h2>\n\t\t\t\t\t\t\t<\/header>\n\t\t\t\n                                            <div class=\"content-item__content-meta badge-container\">                                                                <div class=\"content-item__dates badge badge--flat badge--dates\">\n                                                        <span class=\"content-item__dates--start badge--dates__start\">\n                                avril 16, 2024                            <\/span>\n                                                                                                        <\/div>\n                                                                            <\/div>\n                \t\t<\/div>\n\t\t<div class=\"content-item__content-footer\">\n\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t<\/div>\n\n    <\/article>\n\t\t\t\t\t\t<\/li>\n\t\t\t\t\t\t\t\t<\/ul>\n\t\t\t<\/div>\n<\/nav>\n\n\n\n<h5 class=\"wp-block-heading has-border-color has-has-red-border-color-border-color  mhh-mcn-v1-heading mhh-mcn-v1-heading--af48da851ea1ef6c1d74801f08502c02\" id=\"referrenzen\"><strong><mark style=\"background-color:#ffffff\" class=\"has-inline-color\">R\u00e9f\u00e9rences:<\/mark><\/strong><\/h5>\n\n\n\n<ol class=\"mhh-mcn-v2-clist mhh-mcn-v2-clist--ca2302ff217e72691bf6575c4ce88f69 mhh-mcn-list mhh-mcn-v2-clist--ordered mhh-mcn-v2-clist--ordered-decimal\" dir=\"ltr\" lang=\"fr-FR\" start=\"1\">\n    \n<li class=\"mhh-mcn-list-item mhh-mcn-v2-list-item\">\n    Information professionnelle KEYTRUDA\u00ae, www.swissmedicinfo.ch.    <\/li>\n\n\n<li class=\"mhh-mcn-list-item mhh-mcn-v2-list-item\">\n    Powell SF, et al. Outcomes With Pembrolizumab Plus Platinum-Based Chemotherapy for Patients With NSCLC and Stable Brain Metastases: Pooled Analysis of KEYNOTE-021, -189, and -407. J Thorac Oncol. 2021 Nov;16(11):1883-1892. doi: 10.1016\/j.jtho.2021.06.020.    <\/li>\n\n\n<li class=\"mhh-mcn-list-item mhh-mcn-v2-list-item\">\n    Mansfield AS, et al. Outcomes With Pembrolizumab Monotherapy in Patients With Programmed Death-Ligand 1-Positive NSCLC With Brain Metastases: Pooled Analysis of KEYNOTE-001, 010, 024, and 042. JTO Clin Res Rep. 2021 Jul 1;2(8):100205. doi: 10.1016\/j.jtocrr.2021.100205.    <\/li>\n\n<\/ol>\n\n\n\n<p class=\"has-negative-1-font-size has-border-color has-has-red-border-color-border-color   mhh-mcn-v1-paragraph mhh-mcn-v1-paragraph--a5c809ab247610ad034f11621a90c7ce\"><mark style=\"background-color:#ffffff\" class=\"has-inline-color\">En cas de besoin, des copies des publications d\u2019\u00e9tudes peuvent \u00eatre demand\u00e9es \u00e0 l\u2019adresse dpoc.switzerland@msd.com.<\/mark><\/p>\n\n\n\n<div class=\"wp-block-buttons is-layout-flex wp-block-buttons-is-layout-flex\">\n<div class=\"wp-block-button\"><a class=\"wp-block-button__link wp-element-button\" href=\"https:\/\/swissmedicinfo.ch\/showText.aspx?textType=FI&amp;lang=FR&amp;authNr=66231&amp;supportMultipleResults=1\" target=\"_blank\" rel=\"noreferrer noopener\">Information professionnelle KEYTRUDA\u00ae <\/a><\/div>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>Les analyses group\u00e9es des \u00e9tudes KEYNOTE sur le mNSCLC ont montr\u00e9 un avantage en termes de survie globale m\u00eame chez [&hellip;]<\/p>\n","protected":false},"author":427,"featured_media":67169,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_mhh_sticky_footer_settings":{"entityId":0},"_mhh_sticky_footer_posts":"","_mhh_sticky_footer_expanded":false,"_mhh_mcn_text_direction":"","_mhh_mcn_language":"","_mhh_mcn_left_sidebar_settings":{"entityId":0},"_mhh_mcn_sidebar_settings":{"entityId":0},"mhh_mcn_side_navigation_style":{"fontSize":{"l":"","m":"","s":""},"lineHeight":{"l":1.5,"m":1.5,"s":1.5},"itemColor":"","hoverItemColor":"","currentItemColor":"","borderItemColor":"","backgroundItemHoverColor":"","themeColor":""},"_mhh_mcn_child_page_navigation":{"isActive":false,"isSticky":false},"hide_header":false,"show_top_bar":false,"hide_footer":false,"full_width_layout":false,"icon":null,"job_code":"","hide_featured_image":true,"primary_tag":840,"editor_notices":[],"mconnectHideShareThis":false,"footnotes":"","sidebar_toogle":0,"sidebar_toogle_notification_warning":true,"sidebar_toogle_notification_alert":true,"content_expiration_sidebar_date":"","content_expiration_sidebar_expired_post_status":"","content_expiration_sidebar_redirection":""},"categories":[792],"tags":[840],"ga4_page_audience":[],"ga4_page_birn_id":[],"ga4_page_branding":[957],"ga4_page_businessunit":[963],"ga4_page_campaign":[],"ga4_page_content_purpose":[],"ga4_page_customer_journey_stage":[],"ga4_page_customer_specialty":[],"ga4_page_experience":[],"ga4_page_indication":[],"ga4_page_material_intent":[1206],"ga4_page_product":[],"ga4_page_region":[],"ga4_page_therapeuticarea":[],"tx-therapeutic-area":[627],"tx-product":[],"tx-pathology":[803],"tx-content-type":[],"tx-active-ingredient":[],"access":[],"user_status":[],"user_role":[],"class_list":["post-55767","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-onco-news","tag-cancer-du-poumon"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v23.9 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>KEYTRUDA\u00ae en monoth\u00e9rapie et en association en cas de m\u00e9tastases c\u00e9r\u00e9brales d\u2019un NSCLC avanc\u00e9 - MyMSD.ch FR Onco News<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.mymsd.ch\/fr\/oncology\/onco-news\/keytruda-en-cas-de-metastases-cerebrales-avancees-nsclc\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"KEYTRUDA\u00ae en monoth\u00e9rapie et en association en cas de m\u00e9tastases c\u00e9r\u00e9brales d\u2019un NSCLC avanc\u00e9 - MyMSD.ch FR Onco News\" \/>\n<meta property=\"og:description\" content=\"Les analyses group\u00e9es des \u00e9tudes KEYNOTE sur le mNSCLC ont montr\u00e9 un avantage en termes de survie globale m\u00eame chez [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.mymsd.ch\/fr\/oncology\/onco-news\/keytruda-en-cas-de-metastases-cerebrales-avancees-nsclc\/\" \/>\n<meta property=\"og:site_name\" content=\"MyMSD.ch FR\" \/>\n<meta property=\"article:published_time\" content=\"2022-05-20T11:19:00+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-11-23T18:15:22+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.mymsd.ch\/fr\/wp-content\/uploads\/sites\/30\/2022\/05\/KEYTRUDA-en-monotherapie_S.png\" \/>\n\t<meta property=\"og:image:width\" content=\"635\" \/>\n\t<meta property=\"og:image:height\" content=\"475\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"michaelhuesler1\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"\u00c9crit par\" \/>\n\t<meta name=\"twitter:data1\" content=\"michaelhuesler1\" \/>\n\t<meta name=\"twitter:label2\" content=\"Dur\u00e9e de lecture estim\u00e9e\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/www.mymsd.ch\/fr\/oncology\/onco-news\/keytruda-en-cas-de-metastases-cerebrales-avancees-nsclc\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/www.mymsd.ch\/fr\/oncology\/onco-news\/keytruda-en-cas-de-metastases-cerebrales-avancees-nsclc\/\"},\"author\":{\"name\":\"michaelhuesler1\",\"@id\":\"https:\/\/www.mymsd.ch\/fr\/#\/schema\/person\/0c7449d8e3dcf22b059331a9142e4dde\"},\"headline\":\"KEYTRUDA\u00ae en monoth\u00e9rapie et en association en cas de m\u00e9tastases c\u00e9r\u00e9brales d\u2019un NSCLC avanc\u00e9\",\"datePublished\":\"2022-05-20T11:19:00+00:00\",\"dateModified\":\"2025-11-23T18:15:22+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/www.mymsd.ch\/fr\/oncology\/onco-news\/keytruda-en-cas-de-metastases-cerebrales-avancees-nsclc\/\"},\"wordCount\":102,\"publisher\":{\"@id\":\"https:\/\/www.mymsd.ch\/fr\/#organization\"},\"image\":{\"@id\":\"https:\/\/www.mymsd.ch\/fr\/oncology\/onco-news\/keytruda-en-cas-de-metastases-cerebrales-avancees-nsclc\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.mymsd.ch\/fr\/wp-content\/uploads\/sites\/30\/2022\/05\/KEYTRUDA-en-monotherapie_S.png\",\"keywords\":[\"Cancer du poumon\"],\"articleSection\":[\"Onco News\"],\"inLanguage\":\"fr-FR\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.mymsd.ch\/fr\/oncology\/onco-news\/keytruda-en-cas-de-metastases-cerebrales-avancees-nsclc\/\",\"url\":\"https:\/\/www.mymsd.ch\/fr\/oncology\/onco-news\/keytruda-en-cas-de-metastases-cerebrales-avancees-nsclc\/\",\"name\":\"KEYTRUDA\u00ae en monoth\u00e9rapie et en association en cas de m\u00e9tastases c\u00e9r\u00e9brales d\u2019un NSCLC avanc\u00e9 - MyMSD.ch FR Onco News\",\"isPartOf\":{\"@id\":\"https:\/\/www.mymsd.ch\/fr\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.mymsd.ch\/fr\/oncology\/onco-news\/keytruda-en-cas-de-metastases-cerebrales-avancees-nsclc\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.mymsd.ch\/fr\/oncology\/onco-news\/keytruda-en-cas-de-metastases-cerebrales-avancees-nsclc\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.mymsd.ch\/fr\/wp-content\/uploads\/sites\/30\/2022\/05\/KEYTRUDA-en-monotherapie_S.png\",\"datePublished\":\"2022-05-20T11:19:00+00:00\",\"dateModified\":\"2025-11-23T18:15:22+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/www.mymsd.ch\/fr\/oncology\/onco-news\/keytruda-en-cas-de-metastases-cerebrales-avancees-nsclc\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.mymsd.ch\/fr\/oncology\/onco-news\/keytruda-en-cas-de-metastases-cerebrales-avancees-nsclc\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\/\/www.mymsd.ch\/fr\/oncology\/onco-news\/keytruda-en-cas-de-metastases-cerebrales-avancees-nsclc\/#primaryimage\",\"url\":\"https:\/\/www.mymsd.ch\/fr\/wp-content\/uploads\/sites\/30\/2022\/05\/KEYTRUDA-en-monotherapie_S.png\",\"contentUrl\":\"https:\/\/www.mymsd.ch\/fr\/wp-content\/uploads\/sites\/30\/2022\/05\/KEYTRUDA-en-monotherapie_S.png\",\"width\":635,\"height\":475},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.mymsd.ch\/fr\/oncology\/onco-news\/keytruda-en-cas-de-metastases-cerebrales-avancees-nsclc\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.mymsd.ch\/fr\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"KEYTRUDA\u00ae en monoth\u00e9rapie et en association en cas de m\u00e9tastases c\u00e9r\u00e9brales d\u2019un NSCLC avanc\u00e9\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.mymsd.ch\/fr\/#website\",\"url\":\"https:\/\/www.mymsd.ch\/fr\/\",\"name\":\"MyMSD.ch FR\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\/\/www.mymsd.ch\/fr\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.mymsd.ch\/fr\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.mymsd.ch\/fr\/#organization\",\"name\":\"MSD Switzerland\",\"url\":\"https:\/\/www.mymsd.ch\/fr\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\/\/www.mymsd.ch\/fr\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.mymsd.ch\/fr\/wp-content\/uploads\/sites\/30\/2023\/10\/cropped-myMSD-logo.png\",\"contentUrl\":\"https:\/\/www.mymsd.ch\/fr\/wp-content\/uploads\/sites\/30\/2023\/10\/cropped-myMSD-logo.png\",\"width\":4084,\"height\":692,\"caption\":\"MSD Switzerland\"},\"image\":{\"@id\":\"https:\/\/www.mymsd.ch\/fr\/#\/schema\/logo\/image\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.mymsd.ch\/fr\/#\/schema\/person\/0c7449d8e3dcf22b059331a9142e4dde\",\"name\":\"michaelhuesler1\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\/\/www.mymsd.ch\/fr\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/a15aa52280d3c01526e7127aad7982d2c54f068dc5b17b406fb10311b6eff8ed?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/a15aa52280d3c01526e7127aad7982d2c54f068dc5b17b406fb10311b6eff8ed?s=96&d=mm&r=g\",\"caption\":\"michaelhuesler1\"},\"url\":\"https:\/\/www.mymsd.ch\/fr\/author\/michaelhuesler1\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"KEYTRUDA\u00ae en monoth\u00e9rapie et en association en cas de m\u00e9tastases c\u00e9r\u00e9brales d\u2019un NSCLC avanc\u00e9 - MyMSD.ch FR Onco News","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.mymsd.ch\/fr\/oncology\/onco-news\/keytruda-en-cas-de-metastases-cerebrales-avancees-nsclc\/","og_locale":"fr_FR","og_type":"article","og_title":"KEYTRUDA\u00ae en monoth\u00e9rapie et en association en cas de m\u00e9tastases c\u00e9r\u00e9brales d\u2019un NSCLC avanc\u00e9 - MyMSD.ch FR Onco News","og_description":"Les analyses group\u00e9es des \u00e9tudes KEYNOTE sur le mNSCLC ont montr\u00e9 un avantage en termes de survie globale m\u00eame chez [&hellip;]","og_url":"https:\/\/www.mymsd.ch\/fr\/oncology\/onco-news\/keytruda-en-cas-de-metastases-cerebrales-avancees-nsclc\/","og_site_name":"MyMSD.ch FR","article_published_time":"2022-05-20T11:19:00+00:00","article_modified_time":"2025-11-23T18:15:22+00:00","og_image":[{"width":635,"height":475,"url":"https:\/\/www.mymsd.ch\/fr\/wp-content\/uploads\/sites\/30\/2022\/05\/KEYTRUDA-en-monotherapie_S.png","type":"image\/png"}],"author":"michaelhuesler1","twitter_card":"summary_large_image","twitter_misc":{"\u00c9crit par":"michaelhuesler1","Dur\u00e9e de lecture estim\u00e9e":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.mymsd.ch\/fr\/oncology\/onco-news\/keytruda-en-cas-de-metastases-cerebrales-avancees-nsclc\/#article","isPartOf":{"@id":"https:\/\/www.mymsd.ch\/fr\/oncology\/onco-news\/keytruda-en-cas-de-metastases-cerebrales-avancees-nsclc\/"},"author":{"name":"michaelhuesler1","@id":"https:\/\/www.mymsd.ch\/fr\/#\/schema\/person\/0c7449d8e3dcf22b059331a9142e4dde"},"headline":"KEYTRUDA\u00ae en monoth\u00e9rapie et en association en cas de m\u00e9tastases c\u00e9r\u00e9brales d\u2019un NSCLC avanc\u00e9","datePublished":"2022-05-20T11:19:00+00:00","dateModified":"2025-11-23T18:15:22+00:00","mainEntityOfPage":{"@id":"https:\/\/www.mymsd.ch\/fr\/oncology\/onco-news\/keytruda-en-cas-de-metastases-cerebrales-avancees-nsclc\/"},"wordCount":102,"publisher":{"@id":"https:\/\/www.mymsd.ch\/fr\/#organization"},"image":{"@id":"https:\/\/www.mymsd.ch\/fr\/oncology\/onco-news\/keytruda-en-cas-de-metastases-cerebrales-avancees-nsclc\/#primaryimage"},"thumbnailUrl":"https:\/\/www.mymsd.ch\/fr\/wp-content\/uploads\/sites\/30\/2022\/05\/KEYTRUDA-en-monotherapie_S.png","keywords":["Cancer du poumon"],"articleSection":["Onco News"],"inLanguage":"fr-FR"},{"@type":"WebPage","@id":"https:\/\/www.mymsd.ch\/fr\/oncology\/onco-news\/keytruda-en-cas-de-metastases-cerebrales-avancees-nsclc\/","url":"https:\/\/www.mymsd.ch\/fr\/oncology\/onco-news\/keytruda-en-cas-de-metastases-cerebrales-avancees-nsclc\/","name":"KEYTRUDA\u00ae en monoth\u00e9rapie et en association en cas de m\u00e9tastases c\u00e9r\u00e9brales d\u2019un NSCLC avanc\u00e9 - MyMSD.ch FR Onco News","isPartOf":{"@id":"https:\/\/www.mymsd.ch\/fr\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.mymsd.ch\/fr\/oncology\/onco-news\/keytruda-en-cas-de-metastases-cerebrales-avancees-nsclc\/#primaryimage"},"image":{"@id":"https:\/\/www.mymsd.ch\/fr\/oncology\/onco-news\/keytruda-en-cas-de-metastases-cerebrales-avancees-nsclc\/#primaryimage"},"thumbnailUrl":"https:\/\/www.mymsd.ch\/fr\/wp-content\/uploads\/sites\/30\/2022\/05\/KEYTRUDA-en-monotherapie_S.png","datePublished":"2022-05-20T11:19:00+00:00","dateModified":"2025-11-23T18:15:22+00:00","breadcrumb":{"@id":"https:\/\/www.mymsd.ch\/fr\/oncology\/onco-news\/keytruda-en-cas-de-metastases-cerebrales-avancees-nsclc\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.mymsd.ch\/fr\/oncology\/onco-news\/keytruda-en-cas-de-metastases-cerebrales-avancees-nsclc\/"]}]},{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/www.mymsd.ch\/fr\/oncology\/onco-news\/keytruda-en-cas-de-metastases-cerebrales-avancees-nsclc\/#primaryimage","url":"https:\/\/www.mymsd.ch\/fr\/wp-content\/uploads\/sites\/30\/2022\/05\/KEYTRUDA-en-monotherapie_S.png","contentUrl":"https:\/\/www.mymsd.ch\/fr\/wp-content\/uploads\/sites\/30\/2022\/05\/KEYTRUDA-en-monotherapie_S.png","width":635,"height":475},{"@type":"BreadcrumbList","@id":"https:\/\/www.mymsd.ch\/fr\/oncology\/onco-news\/keytruda-en-cas-de-metastases-cerebrales-avancees-nsclc\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.mymsd.ch\/fr\/"},{"@type":"ListItem","position":2,"name":"KEYTRUDA\u00ae en monoth\u00e9rapie et en association en cas de m\u00e9tastases c\u00e9r\u00e9brales d\u2019un NSCLC avanc\u00e9"}]},{"@type":"WebSite","@id":"https:\/\/www.mymsd.ch\/fr\/#website","url":"https:\/\/www.mymsd.ch\/fr\/","name":"MyMSD.ch FR","description":"","publisher":{"@id":"https:\/\/www.mymsd.ch\/fr\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.mymsd.ch\/fr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"},{"@type":"Organization","@id":"https:\/\/www.mymsd.ch\/fr\/#organization","name":"MSD Switzerland","url":"https:\/\/www.mymsd.ch\/fr\/","logo":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/www.mymsd.ch\/fr\/#\/schema\/logo\/image\/","url":"https:\/\/www.mymsd.ch\/fr\/wp-content\/uploads\/sites\/30\/2023\/10\/cropped-myMSD-logo.png","contentUrl":"https:\/\/www.mymsd.ch\/fr\/wp-content\/uploads\/sites\/30\/2023\/10\/cropped-myMSD-logo.png","width":4084,"height":692,"caption":"MSD Switzerland"},"image":{"@id":"https:\/\/www.mymsd.ch\/fr\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/www.mymsd.ch\/fr\/#\/schema\/person\/0c7449d8e3dcf22b059331a9142e4dde","name":"michaelhuesler1","image":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/www.mymsd.ch\/fr\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/a15aa52280d3c01526e7127aad7982d2c54f068dc5b17b406fb10311b6eff8ed?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a15aa52280d3c01526e7127aad7982d2c54f068dc5b17b406fb10311b6eff8ed?s=96&d=mm&r=g","caption":"michaelhuesler1"},"url":"https:\/\/www.mymsd.ch\/fr\/author\/michaelhuesler1\/"}]}},"_links":{"self":[{"href":"https:\/\/www.mymsd.ch\/fr\/wp-json\/wp\/v2\/posts\/55767","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.mymsd.ch\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.mymsd.ch\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.mymsd.ch\/fr\/wp-json\/wp\/v2\/users\/427"}],"replies":[{"embeddable":true,"href":"https:\/\/www.mymsd.ch\/fr\/wp-json\/wp\/v2\/comments?post=55767"}],"version-history":[{"count":15,"href":"https:\/\/www.mymsd.ch\/fr\/wp-json\/wp\/v2\/posts\/55767\/revisions"}],"predecessor-version":[{"id":102528,"href":"https:\/\/www.mymsd.ch\/fr\/wp-json\/wp\/v2\/posts\/55767\/revisions\/102528"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.mymsd.ch\/fr\/wp-json\/wp\/v2\/media\/67169"}],"wp:attachment":[{"href":"https:\/\/www.mymsd.ch\/fr\/wp-json\/wp\/v2\/media?parent=55767"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.mymsd.ch\/fr\/wp-json\/wp\/v2\/categories?post=55767"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.mymsd.ch\/fr\/wp-json\/wp\/v2\/tags?post=55767"},{"taxonomy":"ga4_page_audience","embeddable":true,"href":"https:\/\/www.mymsd.ch\/fr\/wp-json\/wp\/v2\/ga4_page_audience?post=55767"},{"taxonomy":"ga4_page_birn_id","embeddable":true,"href":"https:\/\/www.mymsd.ch\/fr\/wp-json\/wp\/v2\/ga4_page_birn_id?post=55767"},{"taxonomy":"ga4_page_branding","embeddable":true,"href":"https:\/\/www.mymsd.ch\/fr\/wp-json\/wp\/v2\/ga4_page_branding?post=55767"},{"taxonomy":"ga4_page_businessunit","embeddable":true,"href":"https:\/\/www.mymsd.ch\/fr\/wp-json\/wp\/v2\/ga4_page_businessunit?post=55767"},{"taxonomy":"ga4_page_campaign","embeddable":true,"href":"https:\/\/www.mymsd.ch\/fr\/wp-json\/wp\/v2\/ga4_page_campaign?post=55767"},{"taxonomy":"ga4_page_content_purpose","embeddable":true,"href":"https:\/\/www.mymsd.ch\/fr\/wp-json\/wp\/v2\/ga4_page_content_purpose?post=55767"},{"taxonomy":"ga4_page_customer_journey_stage","embeddable":true,"href":"https:\/\/www.mymsd.ch\/fr\/wp-json\/wp\/v2\/ga4_page_customer_journey_stage?post=55767"},{"taxonomy":"ga4_page_customer_specialty","embeddable":true,"href":"https:\/\/www.mymsd.ch\/fr\/wp-json\/wp\/v2\/ga4_page_customer_specialty?post=55767"},{"taxonomy":"ga4_page_experience","embeddable":true,"href":"https:\/\/www.mymsd.ch\/fr\/wp-json\/wp\/v2\/ga4_page_experience?post=55767"},{"taxonomy":"ga4_page_indication","embeddable":true,"href":"https:\/\/www.mymsd.ch\/fr\/wp-json\/wp\/v2\/ga4_page_indication?post=55767"},{"taxonomy":"ga4_page_material_intent","embeddable":true,"href":"https:\/\/www.mymsd.ch\/fr\/wp-json\/wp\/v2\/ga4_page_material_intent?post=55767"},{"taxonomy":"ga4_page_product","embeddable":true,"href":"https:\/\/www.mymsd.ch\/fr\/wp-json\/wp\/v2\/ga4_page_product?post=55767"},{"taxonomy":"ga4_page_region","embeddable":true,"href":"https:\/\/www.mymsd.ch\/fr\/wp-json\/wp\/v2\/ga4_page_region?post=55767"},{"taxonomy":"ga4_page_therapeuticarea","embeddable":true,"href":"https:\/\/www.mymsd.ch\/fr\/wp-json\/wp\/v2\/ga4_page_therapeuticarea?post=55767"},{"taxonomy":"tx-therapeutic-area","embeddable":true,"href":"https:\/\/www.mymsd.ch\/fr\/wp-json\/wp\/v2\/tx-therapeutic-area?post=55767"},{"taxonomy":"tx-product","embeddable":true,"href":"https:\/\/www.mymsd.ch\/fr\/wp-json\/wp\/v2\/tx-product?post=55767"},{"taxonomy":"tx-pathology","embeddable":true,"href":"https:\/\/www.mymsd.ch\/fr\/wp-json\/wp\/v2\/tx-pathology?post=55767"},{"taxonomy":"tx-content-type","embeddable":true,"href":"https:\/\/www.mymsd.ch\/fr\/wp-json\/wp\/v2\/tx-content-type?post=55767"},{"taxonomy":"tx-active-ingredient","embeddable":true,"href":"https:\/\/www.mymsd.ch\/fr\/wp-json\/wp\/v2\/tx-active-ingredient?post=55767"},{"taxonomy":"access","embeddable":true,"href":"https:\/\/www.mymsd.ch\/fr\/wp-json\/wp\/v2\/access?post=55767"},{"taxonomy":"user_status","embeddable":true,"href":"https:\/\/www.mymsd.ch\/fr\/wp-json\/wp\/v2\/user_status?post=55767"},{"taxonomy":"user_role","embeddable":true,"href":"https:\/\/www.mymsd.ch\/fr\/wp-json\/wp\/v2\/user_role?post=55767"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}